Search research articles
Contact Us
Filters
Showing results (61-70 of 145) with videos related to
Page
of 15
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 1, 1996
Meningeal localization in a patient with Hodgkin's disease. Description of a case and review of the literature
A P Anselmo, A Proia, C Cartoni, et al.
Haematologica
|
July 1, 1985
Methotrexate followed by L-asparaginase for the treatment of acute non lymphoid leukemia
M Tribalto, S Amadori, G Avvisati, et al.
Recenti Progressi in Medicina
|
September 1, 1992
[Recent biological and therapeutic advances in multiple myeloma]
U Coppetelli, G Avvisati, M Tribalto, et al.
Nouvelle Revue Francaise D'Hematologie
|
January 1, 1989
High serum interleukin-2 levels in patients with monoclonal gammopathy of undetermined significance (MGUS) and multiple myeloma
G Cimino, G Avvisati, S Amadori, et al.
Leukemia Research
|
March 1, 1995
Is aggressive chemotherapy the best choice for patients with acute nonlymphocytic leukemia after myelodysplastic syndromes?
R Latagliata, M A Spiriti, G Avvisati, et al.
Medical Oncology (Northwood, London, England)
|
January 10, 2002
Prevention of delayed emesis induced by moderately emetogenic chemotherapy in patients with acute emesis: a pilot study with ACTH-Depot plus tropisetron
D Santini, B Vincenzi, C Fossati, et al.
Bone Marrow Transplantation
|
May 10, 2005
BAVC regimen and autologous bone marrow transplantation for APL patients in second molecular remission: updated results
S Capria, R Latagliata, G Avvisati, et al.
Leukemia
|
June 25, 1998
Polycythemia vera treated with pipobroman as single agent: low incidence of secondary leukemia in a cohort of patients observed during 20 years (1971-1991)
M C Petti, A Spadea, G Avvisati, et al.
Leukemia Research
|
January 1, 1984
Sequential combination of high dose ARA-C (HiDAC) and asparaginase (ASP) for the treatment of advanced acute leukemia and lymphoma
S Amadori, G Papa, G Avvisati, et al.
British Journal of Haematology
|
May 3, 2000
Early haemorrhagic morbidity and mortality during remission induction with or without all-trans retinoic acid in acute promyelocytic leukaemia
E Di Bona, G Avvisati, G Castaman, et al.
Page
of 15
Search research articles
Search
Showing results (61-70 of 145) with videos related to
Sort By:
Page
of 15
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 1, 1996
Meningeal localization in a patient with Hodgkin's disease. Description of a case and review of the literature
A P Anselmo, A Proia, C Cartoni, et al.
Haematologica
|
July 1, 1985
Methotrexate followed by L-asparaginase for the treatment of acute non lymphoid leukemia
M Tribalto, S Amadori, G Avvisati, et al.
Recenti Progressi in Medicina
|
September 1, 1992
[Recent biological and therapeutic advances in multiple myeloma]
U Coppetelli, G Avvisati, M Tribalto, et al.
Nouvelle Revue Francaise D'Hematologie
|
January 1, 1989
High serum interleukin-2 levels in patients with monoclonal gammopathy of undetermined significance (MGUS) and multiple myeloma
G Cimino, G Avvisati, S Amadori, et al.
Leukemia Research
|
March 1, 1995
Is aggressive chemotherapy the best choice for patients with acute nonlymphocytic leukemia after myelodysplastic syndromes?
R Latagliata, M A Spiriti, G Avvisati, et al.
Medical Oncology (Northwood, London, England)
|
January 10, 2002
Prevention of delayed emesis induced by moderately emetogenic chemotherapy in patients with acute emesis: a pilot study with ACTH-Depot plus tropisetron
D Santini, B Vincenzi, C Fossati, et al.
Bone Marrow Transplantation
|
May 10, 2005
BAVC regimen and autologous bone marrow transplantation for APL patients in second molecular remission: updated results
S Capria, R Latagliata, G Avvisati, et al.
Leukemia
|
June 25, 1998
Polycythemia vera treated with pipobroman as single agent: low incidence of secondary leukemia in a cohort of patients observed during 20 years (1971-1991)
M C Petti, A Spadea, G Avvisati, et al.
Leukemia Research
|
January 1, 1984
Sequential combination of high dose ARA-C (HiDAC) and asparaginase (ASP) for the treatment of advanced acute leukemia and lymphoma
S Amadori, G Papa, G Avvisati, et al.
British Journal of Haematology
|
May 3, 2000
Early haemorrhagic morbidity and mortality during remission induction with or without all-trans retinoic acid in acute promyelocytic leukaemia
E Di Bona, G Avvisati, G Castaman, et al.
Page
of 15